Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.77%360.81B | 6.80%1.33T | 5.63%336.5B | 5.98%335.74B | 6.32%326.18B | 9.40%328.7B | 17.13%1.24T | 13.49%318.57B | 18.49%316.79B | 16.91%306.79B |
Cost of revenue | 9.11%276.7B | 6.79%1.03T | 4.33%259.69B | 6.65%260.03B | 6.56%252.64B | 9.82%253.6B | 17.16%960.75B | 14.89%248.91B | 18.21%243.82B | 16.57%237.1B |
Gross profit | 11.99%84.11B | 6.85%301.16B | 10.25%76.8B | 3.76%75.71B | 5.52%73.54B | 8.00%75.1B | 17.03%281.86B | 8.74%69.66B | 19.46%72.97B | 18.08%69.69B |
Operating expense | 11.12%67.14B | 4.18%249.1B | -6.02%65.66B | -4.58%61.17B | 16.60%61.84B | 15.98%60.43B | 24.09%239.11B | 23.15%69.86B | 37.21%64.1B | 16.45%53.04B |
Selling and administrative expenses | 9.84%66.88B | 9.72%247.4B | -3.02%63.25B | 11.54%61.56B | 16.50%61.7B | 16.84%60.89B | --225.48B | --65.22B | --55.19B | --52.96B |
-General and administrative expense | 9.84%66.88B | 9.72%247.4B | -3.02%63.25B | 11.54%61.56B | 16.50%61.7B | 16.84%60.89B | --225.48B | --65.22B | --55.19B | --52.96B |
Other operating expenses | 476.79%323M | -76.40%3.28B | -36.30%2.99B | -99.59%37M | 17.90%191M | 5.66%56M | --13.89B | --4.7B | --8.98B | --162M |
Total other operating income | -88.59%59M | 502.29%1.58B | 948.21%587M | 651.79%421M | -39.08%53M | 720.63%517M | --262M | --56M | --56M | --87M |
Operating profit | 15.61%16.97B | 21.78%52.07B | 5,644.28%11.14B | 64.07%14.54B | -29.73%11.7B | -15.83%14.68B | -11.19%42.75B | -102.74%-201M | -38.29%8.86B | 23.62%16.66B |
Net non-operating interest income (expenses) | 636.78%467M | 62.16%-378M | 71.79%-90M | 95.36%-24M | 9.28%-176M | -380.65%-87M | -352.04%-999M | -564.58%-319M | -875.47%-517M | -246.43%-194M |
Non-operating interest income | 114.29%855M | 61.05%918M | -30.50%180M | 422.81%298M | 0.00%103M | 24.30%399M | 1,063.27%570M | 1,338.89%259M | 375.00%57M | 930.00%103M |
Non-operating interest expense | -20.16%388M | -17.40%1.3B | -53.29%270M | -43.90%322M | -6.06%279M | 67.59%486M | 481.11%1.57B | 775.76%578M | 783.08%574M | 350.00%297M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -766.67%-200M | -22.38%-618M | -32.33%-307M | 46.88%-179M | -871.43%-162M | -30.23%30M | -190.23%-505M | 10.08%-232M | -5,516.67%-337M | 31.25%21M |
Special income (charges) | -2.14B | 0 | ||||||||
Less:Write off | ---- | --2.14B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 17.89%17.23B | 18.61%48.93B | 1,244.15%8.6B | 79.04%14.34B | -31.05%11.37B | -16.52%14.62B | -17.57%41.25B | -109.10%-752M | -46.76%8.01B | 29.39%16.48B |
Income tax | -20.32%3.89B | 2.92%16.95B | 2,626.40%3.16B | -3.84%5.39B | -31.27%3.52B | -16.80%4.88B | 8.17%16.47B | 76.68%-125M | -0.94%5.6B | -0.72%5.12B |
Net income | 37.06%13.34B | 29.05%31.97B | 967.20%5.45B | 272.25%8.95B | -30.95%7.84B | -16.38%9.73B | -28.83%24.78B | -107.14%-628M | -74.39%2.4B | 49.87%11.36B |
Net income continuous operations | 37.06%13.34B | 29.04%31.97B | 968.58%5.45B | 272.14%8.95B | -30.94%7.84B | -16.38%9.73B | -28.83%24.78B | -107.13%-627M | -74.38%2.41B | 49.89%11.36B |
Noncontrolling interests | 6.58%389M | -0.65%2B | 62.09%684M | -17.80%508M | -6.13%444M | -27.15%365M | -30.73%2.02B | -46.85%422M | -28.97%618M | -18.02%473M |
Net income attributable to the company | 38.24%12.95B | 31.68%29.97B | 553.09%4.76B | 372.62%8.44B | -32.03%7.4B | -15.89%9.37B | -28.66%22.76B | -113.13%-1.05B | -79.03%1.79B | 55.49%10.89B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 38.24%12.95B | 31.68%29.97B | 553.09%4.76B | 372.62%8.44B | -32.03%7.4B | -15.89%9.37B | -28.66%22.76B | -113.13%-1.05B | -79.03%1.79B | 55.49%10.89B |
Gross dividend payment | ||||||||||
Basic earnings per share | 38.23%5.72 | 33.00%13.22 | 577.27%2.1 | 363.75%3.71 | -31.01%3.27 | -14.57%4.138 | -28.24%9.94 | -112.67%-0.44 | -78.35%0.8 | 55.87%4.74 |
Diluted earnings per share | 38.48%5.69 | 32.86%13.14 | 575.00%2.09 | 367.09%3.69 | -31.00%3.25 | -14.86%4.109 | -28.60%9.89 | -112.67%-0.44 | -78.62%0.79 | 54.88%4.71 |
Dividend per share | 0 | 40.98%8.6 | 7.50%4.3 | 0 | 104.76%4.3 | 0 | 45.24%6.1 | 81.82%4 | 0 | 5.00%2.1 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |